Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?

Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?

Submitted by admin on March 20, 2022 - 11:03pm
Source: 
Motley Fool
News Tags: 
Pfizer
Novartis
Voyager Therapeutics
AAV capsid
Headline: 
Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?
snippet: 
  • Pfizer and Novartis have licensed Voyager's promising AAV capsid technology.
  • Voyager faces significant risks, especially with no candidates in clinical studies yet.
  • A wait-and-see approach is probably the best one for now with the biotech stock.

Do Not Allow Advertisers to Use My Personal information